Pricing Log in Create free account

Lucid Diagnostics Inc. (LUCD) vs Pulmonx Corporation (LUNG)

Lucid Diagnostics Inc. and Pulmonx Corporation are both Medical Devices companies. Pulmonx Corporation is the larger, with a market value of $111.5M against $79.3M — 1.4× the size. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against −3.15%. Pulmonx Corporation has the higher net margin (−47.9% vs −1,193.9%) and the higher return on invested capital (−129.9% vs −3,096.5%). Across the 17 metrics below, Pulmonx Corporation leads on 13 and Lucid Diagnostics Inc. on 4.

Valuation

Metric LUCD LUNG Medical Devices median
P/E n/m n/m 24.94
P/S 13.45 1.25 2.66
P/B 6.70 3.23 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 11.63 1.07 2.76
Earnings yield (117.50%) (39.63%) (12.66%)
Free cash flow yield (64.42%) (23.17%) (7.18%)

Profitability

Metric LUCD LUNG Medical Devices median
Gross margin (21.69%) 77.42% 57.76%
Operating margin (930.84%) (44.39%) (14.84%)
Net margin (1,193.87%) (47.93%) (14.45%)
Free cash flow margin (866.56%) (28.85%) (5.70%)
Return on equity 364.89% (90.31%) (10.56%)
Return on assets (167.51%) (34.25%) (17.26%)
Return on invested capital (3,096.53%) (129.86%) (5.22%)

Growth

Metric LUCD LUNG Medical Devices median
Revenue growth (TTM) 24.89% (3.15%) 10.41%
EPS growth (last fiscal year) 34.29% 7.64% 28.17%
Revenue growth, 5-year CAGR — 22.55% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LUCD LUNG Medical Devices median
Debt to equity 2.15 1.10 0.04
Current ratio 1.33 4.05 2.67
Net debt to EBITDA 0.22 0.62 0.54

Dividend

Metric LUCD LUNG Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric LUCD LUNG Medical Devices median
Market cap 79.28m 111.49m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack